DocGo Inc.
$0.68
▲
0.26%
2026-04-21 06:23:00
docgo.com
NCM: DCGO
Explore DocGo Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$64.06 M
Current Price
$0.68
52W High / Low
$2.45 / $0.49
Stock P/E
—
Book Value
$1.46
Dividend Yield
—
ROCE
-59.59%
ROE
-89.05%
Face Value
—
EPS
$-1.84
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
2,537
Beta
0.98
Debt / Equity
23.18
Current Ratio
2.26
Quick Ratio
2.26
Forward P/E
2.97
Price / Sales
0.16
Enterprise Value
$11.35 M
EV / EBITDA
-0.15
EV / Revenue
0.04
Rating
None
Target Price
$2.1
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | PACS Group, Inc. | $36 | 28.88 | $5.53 B | — | 6.76% | 22.96% | $43.08 / $7.5 | $6.04 |
| 2. | Basel Medical Group Ltd | $0.62 | — | $10.73 M | — | -25.54% | -1.64% | $9.4 / $0.49 | $0.23 |
| 3. | LifeStance Health Group, Inc. | $6.92 | 277.93 | $2.69 B | — | 1.24% | 0.65% | $8.09 / $3.74 | $3.92 |
| 4. | Universal Health Services, Inc. | $180.51 | 7.82 | $11.04 B | 0.45% | 16.23% | 21.33% | $246.32 / $152.33 | $119.15 |
| 5. | Aveanna Healthcare Holdings Inc. | $6.87 | 6.54 | $1.47 B | — | 16.39% | 6.16% | $10.32 / $3.73 | $0.93 |
| 6. | The Oncology Institute, Inc. | $3.52 | — | $349.89 M | — | -38.51% | 999.19% | $4.88 / $1.8 | $-0.16 |
| 7. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 74.94 M | 70.81 M | 80.42 M | 96.03 M | 120.83 M | — |
| Operating Profit | -32.44 M | -25.24 M | -17.48 M | -14 M | -7.47 M | — |
| Net Profit | -134.07 M | -27.77 M | -11.16 M | -9.41 M | -3.26 M | — |
| EPS in Rs | -1.36 | -0.28 | -0.11 | -0.1 | -0.03 | 0.05 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 322.2 M | 616.56 M | 624.29 M | 440.52 M |
| Operating Profit | -89.16 M | 28.69 M | 15.05 M | 21.83 M |
| Net Profit | -182.4 M | 19.99 M | 6.86 M | 34.58 M |
| EPS in Rs | -1.85 | 0.2 | 0.07 | 0.35 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 217.1 M | 455.62 M | 490.45 M | 393.28 M |
| Total Liabilities | 91.23 M | 140.44 M | 185.28 M | 114.35 M |
| Equity | 144.01 M | 320.92 M | 300.79 M | 273.23 M |
| Current Assets | 152.4 M | 304.49 M | 338.87 M | 271.08 M |
| Current Liabilities | 67.49 M | 121.81 M | 170.12 M | 100.16 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 34.45 M | 70.12 M | -64.49 M | 28.87 M |
| Investing CF | -39.08 M | -10.65 M | -29.61 M | -38.45 M |
| Financing CF | -50.82 M | -24.15 M | 1.12 M | -6.18 M |
| Free CF | 27.02 M | 64.5 M | -74.35 M | 23.37 M |
| Capex | -7.43 M | -5.61 M | -9.85 M | -5.5 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -1.24% | 41.72% | — | — |
| Earnings Growth % | 191.5% | -80.17% | — | — |
| Profit Margin % | 3.24% | 1.1% | 7.85% | — |
| Operating Margin % | 4.65% | 2.41% | 4.96% | — |
| Gross Margin % | 34.64% | 31.3% | 35.12% | — |
| EBITDA Margin % | 7.23% | 5.04% | 7.35% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.